Influenza and Pneumococcal Immunization Program

A complete F-883 §483.80(d) Influenza and Pneumococcal Immunization Program policy plus survey-ready documentation tools for skilled nursing facilities. This template covers pre-admission immunization screening on every admission, the annual influenza vaccination program for residents and staff, the pneumococcal vaccination series administered per ACIP schedule, contraindication and refusal documentation that meets the CMS regulatory expectation, the staff immunization tracking program, the resident education and consent workflow, and the surveyor-encounter workflow CMS uses during F-883 investigations.

F-883 is the third of the three F-tags in the CMS infection control cluster (F-880 IPCP, F-882 antibiotic stewardship, F-883 influenza and pneumococcal immunization). Under 42 CFR §483.80(d)(1), the facility must develop policies and procedures for immunization that include identification of each resident's immunization needs, the timing and spacing of doses, the contraindications and precautions, the consent process, the documentation in the medical record, the availability of vaccines, and the reporting of adverse events. Under §483.80(d)(2), the facility must offer each resident immunization against influenza annually (October 1 through March 31 window) and pneumococcal disease per ACIP schedule, unless medically contraindicated or the resident (or legal representative) refuses. Under §483.80(d)(3), the facility must ensure that each resident and each staff member is offered influenza vaccination annually, with documentation of offer, declination, and contraindication for both populations.

Surveyors cite F-883 when the immunization program exists on paper but does not reliably offer, administer, or document the standard vaccine series at the right time for every resident. The most common citation patterns include: pre-admission immunization screening not documented, annual influenza not offered or documented for residents admitted outside the traditional October–March window, pneumococcal series not completed per ACIP schedule for residents of any age or risk profile, refusal documentation absent or not current, contraindication documentation absent or not signed by a physician, staff immunization program not operated, and adverse event reporting not performed when indicated.

CMS guidance (State Operations Manual, Appendix PP, F-883) treats the immunization program as a per-resident clinical and documentation obligation, not a facility-level checkbox. The surveyor will pull the immunization record for every sampled resident, correlate the record with the admission date, the most recent influenza season, and the ACIP-recommended pneumococcal schedule for the resident's age and risk profile, and identify any resident for whom the offer, administration, refusal, or contraindication chain is incomplete. Surveyors will also pull the staff immunization records and identify any staff member for whom the annual influenza program is not documented. Any resident-level or staff-level break in the chain is a citation.

This template assumes that the Infection Preventionist and the Director of Nursing jointly operate the program, with attending physicians providing medical orders and clinical judgment on contraindications, the Staff Development Coordinator running the in-service program, and the admissions function conducting pre-admission screening at intake. The IP retains operational accountability for program execution. The DON retains clinical accountability for documentation completeness. The attending physicians retain professional accountability for contraindication decisions. The included surveyor-encounter sheet should be walked at minimum 30 days before any anticipated survey window.

Purpose

The purpose of this policy is to establish a single, defensible, surveyor-reviewable Influenza and Pneumococcal Immunization Program under 42 CFR §483.80(d). It defines pre-admission screening, the resident vaccination clinics for both influenza and pneumococcal disease, the documentation requirements for administration, refusal, contraindication, and consent, the staff immunization program, the adverse event reporting workflow, and the documentation chain required to demonstrate that the facility meets the regulatory requirement for every resident and every applicable staff member across every influenza season and every ACIP pneumococcal schedule touchpoint.

Policy

The facility shall operate an Influenza and Pneumococcal Immunization Program that meets the requirements of 42 CFR §483.80(d). The program shall include written policies and procedures that address identification of each resident's immunization needs on admission, the timing and spacing of vaccine doses per current ACIP schedule, the contraindications and precautions per current ACIP guidance, the consent and education process for the resident and the legal representative, the documentation in the resident's medical record, the availability of vaccines, and the reporting of adverse events to the Vaccine Adverse Event Reporting System (VAERS) when indicated. The program shall offer influenza vaccination to every resident and every staff member annually, and shall offer pneumococcal vaccination to every resident per ACIP schedule, unless medically contraindicated or refused by the resident or the legal representative.

Scope

This policy applies to all residents admitted to the facility for skilled nursing or long-term care, regardless of payer source, length of stay, age, or vaccination history. It applies to all facility staff (employees, contracted clinical staff, contracted non-clinical staff with resident contact, and volunteers with resident contact) for the annual influenza vaccination program. It applies to the Infection Preventionist and the Director of Nursing operating the clinical and documentation workflow, to the attending physicians providing medical orders and contraindication judgment, to the admissions function performing pre-admission screening at intake, to the Staff Development Coordinator running staff in-service and tracking, and to the administrator for resource support.

Procedure

Pre-admission immunization screening

The admissions function shall perform a documented pre-admission immunization screen for every resident at intake. The screen shall include: history of influenza vaccination for the most recent season and any prior seasons, history of pneumococcal vaccination series (PCV13, PCV15, PCV20, PPSV23 as applicable to the resident's age and risk profile), date of most recent doses, identification of any ACIP contraindications or precautions, identification of any documented refusals or exemptions for prior doses, and consent status for the upcoming influenza season if within the October–March window. The screen shall be retained in the resident's medical record and shall be reviewed by the IP within 24 hours of admission.

Resident influenza vaccination program

The facility shall offer influenza vaccination to every resident annually. The program shall operate within the ACIP-recommended October 1 through March 31 vaccination window, with extension as product availability and epidemiology warrant. The vaccination shall be ordered by the attending physician, administered per facility protocol (commonly by the IP or a licensed nurse), documented in the resident's medical record at the time of administration, and recorded in the resident-specific immunization record. Any refusal shall be documented with the resident-specific rationale and signed by the resident or the legal representative. Any contraindication shall be documented by the attending physician with the clinical rationale and signed by the physician.

Resident pneumococcal vaccination program

The facility shall offer pneumococcal vaccination to every resident per current ACIP schedule. The schedule shall be applied to the resident's age and clinical risk profile. For adults 65 years and older, the current ACIP recommendation (PCV20 alone, PCV15 followed by PPSV23, or PCV13 per shared clinical decision-making for immunocompetent residents) shall be applied with documentation of the schedule selected and the rationale. For adults 19–64 years of age with ACIP-defined risk conditions, the risk-based schedule (PCV20 alone, PCV15 followed by PPSV23, or PCV13 per shared clinical decision-making) shall be applied with documentation of the risk condition. Pneumococcal vaccination history shall be screened at intake, and any dose gaps shall be completed on the ACIP-recommended timeline.

Consent and education

Influenza and pneumococcal vaccination shall be offered with documented education. Education shall cover: the disease being prevented, the vaccine being administered, the ACIP schedule being applied, common and serious potential adverse events, the right to refuse and the right to withdraw consent at any time, and the alternative if the resident declines. Education shall be delivered to the resident or the legal representative (as applicable) at a level appropriate to the audience, documented in the medical record, and signed by the resident or the legal representative before administration.

Operational elements

Staff immunization program

The facility shall offer annual influenza vaccination to every staff member (employees, contracted clinical staff, contracted non-clinical staff with resident contact, and volunteers with resident contact). The offer shall be documented for every staff member each season, with documentation of administration, refusal, contraindication, or off-site receipt. The staff immunization tracking record shall be retained for the trailing 5 influenza seasons. The program shall be operated jointly by the IP and the Staff Development Coordinator, with administrator support for staff scheduling to support the offer being made.

Refusal and contraindication documentation

Refusal shall be documented with the resident-specific rationale, the education provided, the alternative offered, and the signature of the resident or the legal representative. Refusal documentation shall be retained in the resident's medical record and shall be revisited each season or each dose interval as applicable. Contraindication shall be documented by the attending physician with the clinical rationale, the ACIP classification of the contraindication or precaution, and the physician signature. Contraindication decisions shall be reviewed at minimum annually and reconsidered as the resident's clinical condition evolves.

Documentation of administration

Administration shall be documented at the time of administration with: vaccine name, lot number, manufacturer, expiration date, dose, route, site of administration, date and time, name of administering clinician, and any immediate adverse event. Documentation shall be entered in the resident's medical record, the resident-specific immunization record, and any required state immunization registry.

Adverse event reporting

Any adverse event following immunization shall be documented and reported to VAERS when applicable per federal reporting criteria, with documentation of the report in the resident's medical record. Adverse events that result in clinical intervention shall also be reported to the attending physician and reviewed in the QAPI committee. The reporting workflow shall be documented and retained in the program policy.

QAPI integration

Program outcomes shall be reviewed at the QAPI committee at minimum quarterly. The committee shall review: percentage of residents offered influenza vaccination each season with offer documented (target 100%); percentage of residents with documented refusal or contraindication; pneumococcal series completion rate per ACIP schedule; staff immunization offer and documentation rates; any adverse event reports; and any program change with target completion date. The QAPI feedback loop shall be documented in committee minutes.

Documentation

Documentation generated by this policy shall include: the program policy and all program procedures; pre-admission immunization screening records; resident immunization records per vaccine and per dose; consent and education documentation; refusal documentation with resident-specific rationale; contraindication documentation with physician signature; administration documentation per dose with lot number and administering clinician; any adverse event reports and corresponding VAERS submissions; staff immunization offer, administration, refusal, and contraindication records for the trailing 5 seasons; QAPI committee minutes referencing immunization program content; and the annual program review documentation. Documentation shall be retained per facility policy (commonly indefinitely for the resident immunization record and the policy itself, with a minimum of 5 seasons for the staff immunization tracking) and shall be retrievable within surveyor timeframes.

Surveyor-encounter sheet

When the surveyor requests F-883 documentation, the facility shall produce, in order: (1) the immunization program policy and procedures; (2) the pre-admission immunization screening records for sampled residents; (3) the resident immunization records per sampled resident covering the most recent influenza season and the ACIP pneumococcal schedule touchpoints for the resident's age and risk profile; (4) the consent, refusal, and contraindication documentation for sampled residents; (5) the administration documentation with lot number and administering clinician for sampled doses; (6) the staff immunization program records for the trailing 5 seasons, including the offer documentation; (7) any VAERS reports and corresponding adverse event documentation; (8) the QAPI committee minutes referencing immunization content; (9) the cross-reference to the IPCP (F-880). The facility shall be ready to produce this documentation set within surveyor timeframes on Day 1 of survey.

Survey prep checklist

The IP and the DON shall complete a 30-day pre-survey F-883 audit covering: pre-admission immunization screening currency (target ≥ 95% of admissions in the trailing 90 days); annual influenza offer and documentation currency for every resident (target 100%); refusal and contraindication documentation completeness for any resident who refused or was contraindicated (target 100%); pneumococcal series completion per ACIP schedule per resident profile; consent and education documentation currency; administration documentation completeness (lot number, administering clinician, date and time) for sampled doses (target 100%); staff immunization offer and documentation currency for the current season; QAPI committee minutes currency with immunization content; VAERS reporting for any documented adverse event. Audit findings and corrective action documentation shall be retained in the survey binder for the trailing 12 months.

References

Primary regulatory authority: 42 CFR §483.80(d)(1)–(3) — Influenza and Pneumococcal Immunization. CMS State Operations Manual, Appendix PP — Guidance to Surveyors for Long Term Care Facilities, F-883 (cross-referencing F-880 IPCP and QAPI §483.75). Advisory Committee on Immunization Practices (ACIP) annual influenza recommendations and current pneumococcal vaccination schedule for adults. CDC long-term care facility immunization guidance. Vaccine Adverse Event Reporting System (VAERS) federal reporting criteria. State-specific immunization registry reporting requirements. Manufacturer prescribing information for each vaccine administered. Facility IPCP policy (F-880) and QAPI program plan.